Brokerages predict that MedEquities Realty Trust Inc (NYSE:MRT) will report earnings of $0.31 per share for the current quarter, Zacks reports. Three analysts have issued estimates for MedEquities Realty Trust’s earnings, with estimates ranging from $0.30 to $0.32. MedEquities Realty Trust reported earnings per share of $0.27 during the same quarter last year, which indicates a positive year over year growth rate of 14.8%. The business is expected to report its next quarterly earnings results on Monday, February 26th.

On average, analysts expect that MedEquities Realty Trust will report full year earnings of $1.12 per share for the current fiscal year, with EPS estimates ranging from $1.11 to $1.13. For the next fiscal year, analysts anticipate that the company will post earnings of $1.26 per share, with EPS estimates ranging from $1.18 to $1.34. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that follow MedEquities Realty Trust.

MedEquities Realty Trust (NYSE:MRT) last released its quarterly earnings data on Tuesday, November 7th. The financial services provider reported $0.17 EPS for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.13). MedEquities Realty Trust had a net margin of 35.61% and a return on equity of 5.88%. The business had revenue of $15.77 million during the quarter, compared to analysts’ expectations of $15.49 million.

A number of analysts recently issued reports on MRT shares. KeyCorp reissued a “buy” rating and issued a $13.00 target price on shares of MedEquities Realty Trust in a research report on Tuesday, September 26th. Capital One Financial started coverage on MedEquities Realty Trust in a research report on Monday, October 23rd. They issued an “equal weight” rating and a $13.00 target price for the company. B. Riley reissued a “buy” rating on shares of MedEquities Realty Trust in a research report on Wednesday, November 1st. Zacks Investment Research raised MedEquities Realty Trust from a “sell” rating to a “hold” rating and set a $12.00 target price for the company in a research report on Wednesday, November 15th. Finally, ValuEngine raised MedEquities Realty Trust from a “hold” rating to a “buy” rating in a research report on Friday, December 1st. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $13.00.

In related news, CEO John W. Mcroberts acquired 18,000 shares of the firm’s stock in a transaction on Friday, November 17th. The stock was bought at an average cost of $10.74 per share, with a total value of $193,320.00. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Randy L. Churchey acquired 5,300 shares of the firm’s stock in a transaction on Monday, November 20th. The shares were bought at an average cost of $10.87 per share, with a total value of $57,611.00. Following the completion of the transaction, the director now directly owns 46,776 shares in the company, valued at approximately $508,455.12. The disclosure for this purchase can be found here. Insiders have acquired a total of 23,600 shares of company stock valued at $254,129 over the last ninety days. 2.50% of the stock is owned by insiders.

Institutional investors have recently bought and sold shares of the business. JPMorgan Chase & Co. acquired a new stake in MedEquities Realty Trust during the 3rd quarter worth approximately $118,000. Raymond James Financial Services Advisors Inc. acquired a new stake in MedEquities Realty Trust during the 2nd quarter worth approximately $154,000. Alliancebernstein L.P. acquired a new stake in MedEquities Realty Trust during the 2nd quarter worth approximately $175,000. Cubist Systematic Strategies LLC acquired a new stake in MedEquities Realty Trust during the 3rd quarter worth approximately $177,000. Finally, Dynamic Technology Lab Private Ltd lifted its position in MedEquities Realty Trust by 25.1% during the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 16,686 shares of the financial services provider’s stock worth $210,000 after acquiring an additional 3,346 shares during the period. 93.19% of the stock is owned by institutional investors.

Shares of MedEquities Realty Trust (MRT) traded down $0.17 during midday trading on Friday, hitting $10.84. The company had a trading volume of 360,700 shares, compared to its average volume of 198,222. The firm has a market cap of $344.23, a PE ratio of 27.10 and a beta of -0.74. MedEquities Realty Trust has a 1 year low of $10.06 and a 1 year high of $13.06.

ILLEGAL ACTIVITY WARNING: This piece of content was published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of US & international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/analysts-anticipate-medequities-realty-trust-inc-mrt-will-announce-earnings-of-0-31-per-share/1808568.html.

About MedEquities Realty Trust

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.